For example, the levels of serum exosomal lncRNA GAS5 in patients with early-stage NSCLC were found to be lower than those in healthy individuals, and with even lower levels observed in patients with advanced NSCLC. This evidence concerns the gene GAS5 and non-small cell lung carcinoma.